Seborrheic dermatitis treatment with stellate ganglion block: a case report
Gun Woo Kim1, Ki Ho Mun1, Jeong Yun Song1
1Department of Anesthesiology and Pain Medicine, Inha University College of Medicine, Incheon, Korea.
Korean Journal of Anesthesiology
|April 12, 2016
Summary
Stellate ganglion block (SGB) offers a novel treatment for seborrheic dermatitis, a chronic inflammatory skin condition. Repeated SGB trials successfully improved a patient's condition, suggesting a new therapeutic avenue.
Area of Science:
- Dermatology and Neurology
- Autonomic Nervous System Research
Background:
- Seborrheic dermatitis is a chronic inflammatory skin condition.
- Its pathogenesis involves sebaceous gland activity, microflora, and immune responses.
- Stellate ganglion block (SGB) influences autonomic, endocrine, and immune functions.
Purpose of the Study:
- To investigate the potential of stellate ganglion block (SGB) as a treatment for seborrheic dermatitis.
- To report the first case of successful seborrheic dermatitis treatment using SGB.
Main Methods:
- The study involved repeated stellate ganglion block (SGB) trials on a patient with seborrheic dermatitis.
- SGB is known to modulate sympathetic nerve activity and blood flow.
Main Results:
- Successful treatment of seborrheic dermatitis was achieved through repeated SGB trials.
- SGB demonstrated efficacy in managing this chronic inflammatory skin disorder.
Conclusions:
- Stellate ganglion block (SGB) presents a promising new therapeutic option for seborrheic dermatitis.
- Further research is warranted to explore SGB's role in managing inflammatory skin conditions.
